BH
The startup has developed a diagnostic platform that utilizes cognitive assessments and brain imaging to identify early indicators of Alzheimer's disease and other dementias. By analyzing brain activity and structure, the platform enables healthcare professionals to implement personalized interventions aimed at delaying cognitive decline before symptoms manifest.
Updated 3 months ago
Funding
$2.9M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup has developed a diagnostic platform that utilizes cognitive assessments and brain imaging to identify early indicators of Alzheimer's disease and other dementias. By analyzing brain activity and structure, the platform enables healthcare professionals to implement personalized interventions aimed at delaying cognitive decline before symptoms manifest.